Protein Binding of First-Line Antituberculosis Drugs

por Alghamdi, Wael A., Al-Shaer, Mohammad H., Peloquin, Charles A.
Publicado en Antimicrob Agents Chemother (2018)

Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series

por Alghamdi, Wael A., Al‐Shaer, Mohammad H., Klinker, Kenneth P., Peloquin, Charles A.
Publicado en Clin Case Rep (2020)

A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment

por Kempker, Russell R., Alghamdi, Wael A., Al-Shaer, Mohammad H., Burch, Gena, Peloquin, Charles A.
Publicado en Antimicrob Agents Chemother (2019)

Correction for Kempker et al., “A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment”

por Kempker, Russell R., Alghamdi, Wael A., Al-Shaer, Mohammad H., Burch, Gena, Peloquin, Charles A.
Publicado en Antimicrob Agents Chemother (2020)

Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia

por Alsultan, Abdullah, Alghamdi, Wael A., Alghamdi, Jahad, Alharbi, Abeer F., Aljutayli, Abdullah, Albassam, Ahmed, Almazroo, Omar, Alqahtani, Saeed
Publicado en Saudi Pharm J (2020)

Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis

por Alghamdi, Wael A, Al-Shaer, Mohammad H, Kipiani, Maia, Barbakadze, Ketevan, Mikiashvili, Lali, Kempker, Russell R, Peloquin, Charles A
Publicado en J Antimicrob Chemother (2020)

Population pharmacokinetics of efavirenz in HIV and TB/HIV coinfected children: the significance of genotype-guided dosing

por Alghamdi, Wael A, Antwi, Sampson, Enimil, Anthony, Yang, Hongmei, Dompreh, Albert, Wiesner, Lubbe, Langaee, Taimour, Peloquin, Charles A, Kwara, Awewura
Publicado en J Antimicrob Chemother (2019)

Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis

por Alghamdi, Wael A., Al-Shaer, Mohammad H., An, Guohua, Alsultan, Abdullah, Kipiani, Maia, Barbakadze, Ketevan, Mikiashvili, Lali, Ashkin, David, Griffith, David E., Cegielski, J. Peter, Kempker, Russell R., Peloquin, Charles A.
Publicado en Antimicrob Agents Chemother (2020)

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection

por Al-Shaer, Mohammad H., Alghamdi, Wael A., Alsultan, Abdullah, An, Guohua, Ahmed, Shahriar, Alkabab, Yosra, Banu, Sayera, Barbakadze, Ketevan, Houpt, Eric, Kipiani, Maia, Mikiashvili, Lali, Cegielski, J. Peter, Kempker, Russell R., Heysell, Scott K., Peloquin, Charles A.
Publicado en Antimicrob Agents Chemother (2019)

Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years Old

por Enimil, Anthony, Antwi, Sampson, Yang, Hongmei, Dompreh, Albert, Alghamdi, Wael A., Gillani, Fizza S., Orstin, Antoinette, Bosomtwe, Dennis, Opoku, Theresa, Norman, Jennifer, Wiesner, Lubbe, Langaee, Taimour, Peloquin, Charles A., Court, Michael H., Greenblatt, David J., Kwara, Awewura
Publicado en Antimicrob Agents Chemother (2019)

Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis

por Al-Shaer, Mohammad H., Märtson, Anne-Grete, Alghamdi, Wael A., Alsultan, Abdullah, An, Guohua, Ahmed, Shahriar, Alkabab, Yosra, Banu, Sayera, Houpt, Eric R., Ashkin, David, Griffith, David E., Cegielski, J. Peter, Heysell, Scott K., Peloquin, Charles A.
Publicado en Antimicrob Agents Chemother (2020)

Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old

por Kwara, Awewura, Yang, Hongmei, Antwi, Sampson, Enimil, Anthony, Gillani, Fizza S., Dompreh, Albert, Ortsin, Antoinette, Opoku, Theresa, Bosomtwe, Dennis, Sarfo, Anima, Wiesner, Lubbe, Norman, Jennifer, Alghamdi, Wael A., Langaee, Taimour, Peloquin, Charles A., Court, Michael H., Greenblatt, David J.
Publicado en Antimicrob Agents Chemother (2018)

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis

por Alghamdi, Wael A., Alsultan, Abdullah, Al-Shaer, Mohammad H., An, Guohua, Ahmed, Shahriar, Alkabab, Yosra, Banu, Sayera, Barbakadze, Ketevan, Houpt, Eric, Kipiani, Maia, Mikiashvili, Lali, Schmidt, Stephan, Heysell, Scott K., Kempker, Russell R., Cegielski, J. Peter, Peloquin, Charles A.
Publicado en Antimicrob Agents Chemother (2019)

Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients

por Singh, Sonal, McDonough, Caitrin W., Gong, Yan, Alghamdi, Wael A., Arwood, Meghan J., Bargal, Salma A., Dumeny, Leanne, Li, Wen‐Yi, Mehanna, Mai, Stockard, Bradley, Yang, Guang, de Oliveira, Felipe A., Fredette, Natalie C., Shahin, Mohamed H., Bailey, Kent R., Beitelshees, Amber L., Boerwinkle, Eric, Chapman, Arlene B., Gums, John G., Turner, Stephen T., Cooper‐DeHoff, Rhonda M., Johnson, Julie A.
Publicado en J Am Heart Assoc (2018)